Impact of Genotype–Phenotype Associations on Prognosis in Dilated Cardiomyopathy

Patients with a genetic form of DCM exhibit clinical and genetic heterogeneity. Genotype-based risk stratification is more accurate compared to a phenotype-first approach, highlighting the importance of broad genetic screening among patients with DCM. Additionally, gene-specific risk prediction should become more prominent in current guidelines on management of genetic DCM patients.

Authors

Institutions

Publication Details

Journal
European Journal of Heart Failure
Published
2025-09-12
DOI
https://doi.org/10.1002/ejhf.70040
Citations
4
Primary Topic
Cardiomyopathy and Myosin Studies
Type
article
Field-Weighted Citation Impact
5.55

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of Genotype–Phenotype Associations on Prognosis in Dilated Cardiomyopathy

Sharon Graw, Job A.J. Verdonschot, Nerea Mora Ayestarán, Kristen Medo et al.
4 citations
European Journal of Heart Failure
Cardiomyopathy and Myosin Studies
5.55
article

Impact of Genotype–Phenotype Associations on Prognosis in Dilated Cardiomyopathy

Sharon Graw, Job A.J. Verdonschot, Nerea Mora Ayestarán, Kristen Medo, Sophie L.V.M. Stroeks, Gianfranco Sinagra, Fernándo Domínguez, Max F.G.H.M. Venner, Steven A. Muller, Marco Merlo, Matteo Dal Ferro, Pablo García‐Pavía, Stéphane Heymans, Matthew R.G. Taylor, Maurits A. Sikking, Luisa Mestroni, Bart de Koning, Alessia Paldino, J. Peter van Tintelen, Anneline S.J.M. te Riele, Michiel Minten, Ping Wang, Esther Gonzalez-Lopez, Max Jason, Arthur van den Wijngaard, Bastien Nihant, Nina J Beelen, Carola Pio Loca
article en
4 citations

Abstract

Patients with a genetic form of DCM exhibit clinical and genetic heterogeneity. Genotype-based risk stratification is more accurate compared to a phenotype-first approach, highlighting the importance of broad genetic screening among patients with DCM. Additionally, gene-specific risk prediction should become more prominent in current guidelines on management of genetic DCM patients.

European Journal of Heart FailureVol. 27(12)
Utrecht University (NL), University Medical Center (US), University Medical Center Utrecht (NL), Maastricht University (NL), Centro de Investigación en Red en Enfermedades Cardiovasculares (ES), Centro Nacional de Epidemiología (ES), Centro Nacional de Biotecnología (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Netherlands Heart Institute (NL), Spanish National Centre for Cardiovascular Research (ES), ERN GUARD-Heart (NL), Azienda Sanitaria Universitaria Integrata di Trieste (IT), University of Colorado Anschutz Medical Campus (US), KU Leuven (BE)
European Federation of Pharmaceutical Industries and Associations, European Commission, ZonMw, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, HORIZON EUROPE European Innovation Council
Openalex Percentile: Top 4%
Cardiomyopathy and Myosin Studies
5.55
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.